Cell Signaling Technology

Phospho-CSF-1R/M-CSF-R (Tyr809) Antibody

#3154 · $362

100
Citing papers
12.1k
Combined citations
Supplier page Find this product

Research areas

Cytokine Signaling Pathways and Interactions9Immune Response and Inflammation8Immune Cell Function and Interaction6Cancer, Hypoxia, and Metabolism6Cancer-related molecular mechanisms research6Cell Adhesion Molecules Research5Angiogenesis and VEGF in Cancer5interferon and immune responses5

Papers citing this product

1
Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus
Journal of Biological Chemistry·2004·672 cit.·DOI
2
HDAC3 Is a Critical Negative Regulator of Long-Term Memory Formation
Journal of Neuroscience·2011·504 cit.·DOI
3
Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3
Journal of Allergy and Clinical Immunology·2004·351 cit.·DOI
4
Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects
Diabetes·2006·281 cit.·DOI
5
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway
Nature Communications·2020·273 cit.·DOI
6
STAT2 deficiency and susceptibility to viral illness in humans
Proceedings of the National Academy of Sciences·2013·246 cit.·DOI
7
Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion
Nature Communications·2022·241 cit.·DOI
8
Respiratory Syncytial Virus Induces TLR3 Protein and Protein Kinase R, Leading to Increased Double-Stranded RNA Responsiveness in Airway Epithelial Cells
The Journal of Immunology·2006·241 cit.·DOI
9
Ligand-regulated Chimeric Receptor Approach Reveals Distinctive Subcellular Localization and Signaling Properties of the Toll-like Receptors
Journal of Biological Chemistry·2004·234 cit.·DOI
10
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens
Scientific Reports·2020·220 cit.·DOI